CANMab 440 mg Injection Biocon

CANMab 440 mg Injection Biocon

19000 INR

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Function Breast Cancer
  • Dosage 400 Mg
  • Suitable For Suitable For All
  • Storage Instructions Dry Place
  • Click to View more
X

CANMab 440 mg Injection Biocon Price And Quantity

  • 5 Box
  • 19000 INR

CANMab 440 mg Injection Biocon Product Specifications

  • Dry Place
  • 400 Mg
  • Breast Cancer
  • Injection
  • Suitable For All
  • Liquid

CANMab 440 mg Injection Biocon Trade Information

  • Cheque
  • 5 Box Per Day
  • 2-3 Days
  • Carton Box.
  • Australia Eastern Europe Western Europe Africa Middle East South America Asia Central America North America
  • All India

Product Description

CANMAb(TM) 440 mg Injection which contains trastuzumab used for the treatment of HER2-positive metastatic breast cancer in India. CANMAb(TM), developed jointly by Biocon Pharma and Mylan under a global partnership, is being introduced for the benefit of patients in India. Breast cancer is the most prevalent cancer among Indian women ahead of cervical cancer and CANMAb(TM) will offer a high quality, more affordable option to breast cancer patients in India. 

Other Products in 'Botox Injections' category



Get in touch with us
RFQ Request For Quotation
Get Quotes For Your Buying Requirement. Tell Suppliers What You Need.
I agree to abide by all the Terms and Conditions of tradeindia.com